CD274 and neoplasm: Expression of PD-L1 protein [8], effector T-cell gene expression [9], tumor mutational burden (TMB) measured in tumor tissue or peripheral blood [10, 11], Eastern Co-operative Oncology Group (ECOG) performance status, and routine hematological indicators such as peripheral blood cell counts and lactate dehydrogenase have been proposed to identify prognosis.